F18 RADIOPHARMACEUTICALS

SOL #: 36C24726Q0232Sources Sought

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
247-NETWORK CONTRACT OFFICE 7 (36C247)
AUGUSTA, GA, 30904, United States

Place of Performance

Decatur, GA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Nuclear Medicine (Q527)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 21, 2026
2
Response Deadline
Jan 26, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA) is conducting a Sources Sought / Market Survey to identify qualified vendors for the daily delivery of F18 Radiopharmaceuticals to the Atlanta VA Medical Center in Decatur, GA. This market research aims to determine the appropriate acquisition method. Responses are due by January 26, 2026.

Scope of Work

The vendor shall provide daily delivery of various F18 radiopharmaceuticals, including F18-FDG, NaF-F18, F18-beta-amyloid imaging agent, F18-Axumin, F18-Tauvid, F18-Cerianna, F18-Posluma, F18-Pylarify, CAIX Radiopharmaceutical, choline PET radiopharmaceuticals, and F18-FET. Deliveries are required between 7:00 AM and 5:00 PM, with provisions for emergency deliveries.

Key Vendor Requirements:

  • Established commercial radiopharmacy with 10+ years of continuous operation.
  • System for order, shipment, delivery, and return of spent syringes, compliant with OSHA Biohazardous Waste Policy/Regulations (needleless system).
  • Licensed by the US NRC and/or an Agreement State to prepare and distribute radiopharmaceuticals; copies of license and inspection reports must be provided.
  • Documentation that cyclotrons used are FDA approved for commercial use.
  • Accept returns for full credit under specified conditions (e.g., product error, damage, recall, expiration).

Information Requested

Interested parties should submit:

  1. Company name, address, phone number, primary contact(s), e-mail address, NAICS code(s), business size (small/large), and UEI Number.
  2. A Statement of Capability (maximum 5 pages) demonstrating past performance relevant to the requirements.

Contract & Timeline

  • Type: Sources Sought / Market Survey
  • Set-Aside: Special interest in Service Disabled Veteran Owned Businesses (SDVOSB), Veteran Owned Small Businesses (VOSB), and Small Business Concerns.
  • NAICS Code: 325412
  • Response Due: January 26, 2026, 4:00 PM EST
  • Published: January 21, 2026

Additional Notes

This notice is for planning purposes only and does not constitute a solicitation or commitment by the Government to award a contract. Responses will not be considered adequate for a future solicitation. Proprietary, classified, or sensitive information should not be included. A future notice will be posted when a solicitation is released.

People

Points of Contact

Natasha MixonPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Sources Sought
Posted: Jan 21, 2026
F18 RADIOPHARMACEUTICALS | GovScope